欧洲疾控中心-对非HIV免疫功能低下个体接种HPV疫苗的疗效、有效性、免疫原性和安全性的系统评价和荟萃分析（英）

A systematic review and meta-analyses of the efficacy, effectiveness, immunogenicity and safety of HPV vaccination in non-HIV immunocompromised individualsASSESSMENTECDC ASSESSMENT A systematic review and meta-analyses of the efficacy, effectiveness, immunogenicity and safety of HPV vaccination in non-HIV immunocompromised individuals ii This report was commissioned by the European Centre for Disease Prevention and Control (ECDC), as part of the activities of the ECDC NITAG Collaboration, in close cooperation with the European Commission and the European Health and Digital Executive Agency. The commissioning and production of this review was coordinated by Kate Olsson (ECDC) and Karam Adel Ali (ECDC). Authors Philipp Kapp [Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany]; Waldemar Siemens [Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany]; Lea Gorenflo [Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany]; Henriette Schulz [Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany]; Yuan Chi [Beijing Yealth Technology Co., Ltd, Beijing, China]; Irma Klerings [Universität Krems, Krems, Austria]; Marianne Röbl-Mathieu [Gynaecologist, Munich, Germany]; Mona Askar [Immunization Unit, Robert Koch-Institute, Berlin, Germany]; María Brotons [Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute – IDIBELL. L’Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health – CIBERESP, Madrid, Spain]; Peter Henrik Andersen [Department of Infectious Disease Epidemiology, SSI, Copenhagen, Denmark]; Deborah Konopnicki [Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium]; Judi Lynch [National Cervical Screening Laboratory, The Coombe Hospital, Dublin, Ireland]; Simona Ruţă [Carol Davila University of Medicine and Pharmacy & Stefan S. Nicolau Institute of Virology, Bucharest, Romania]; Liisa Saare [Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia]; Béatrice Swennen [Public Health School, Université Libre de Bruxelles, Brussels, Belgium]; Ruth Tachezy [Faculty of Science BIOCEV Charles University, Prague, Czech Republic]; Anja Takla [Immunization Unit, Robert Koch-Institute, Berlin, Germany]; Veronika Učakar [National Institute of Public Health, Ljubljana, Slovenia]; Simopekka Vanska [Finish Institute for Health and Welfare, Helsinki, Finland]; Dace Zavadska [Rīgas Stradiņa Universitāte, Riga, Latvia]; Karam Adel Ali [European Cen